• Investors

Appointment of a new director

We are very pleased to announce that Dr. Michael McCullar, who has extensive experience in the management and business development aspects of biotech ventures, has joined our Board of Directors.
He has sold ventures to several companies, including Japanese pharmaceutical companies, where he was responsible for business development. He has a proven track record of leading cross-border organizations in the US, Europe, and Asia.